Six commonsense questions informing the 5-year outlook for healthcare AI: An excerpt from our report

AI discussion is everywhere, currently infusing the whole of the healthcare news and insight ecosystem. And yet, it remains an exceptionally difficult topic for many healthcare leaders to write, read, or talk about in a meaningful way. 

Yulan Egan
Yulan Egan
Updated Jul 19, 2024 8 min read

At a glance

AI discussion is everywhere, currently infusing the whole of the healthcare news and insight ecosystem. And yet, it remains an exceptionally difficult topic for many healthcare leaders to write, read, or talk about in a meaningful way.

To bring clarity, Union’s newest research report (which members may access in full here) is aimed at a specific audience and time horizon. As always, we are addressing the healthcare executive generalist: individuals who are conversant in the industry at large but who constantly need updated understanding across the many strategically important domains they track. This includes general management executives, board members, and strategy leaders, among others. We believe that this group is typically best served by an explicit three-to-five year outlook. This timeframe ensures discussion is forward-looking, but not overly futuristic in nature. It also aligns with a typical strategic planning cycle. To further ground the discussion, we emphasize a “commonsense” view and a question/answer structure for the work (more on this a moment).

To frame this work, we began with the truism that AI is both over-hyped and under-leveraged. It’s traveling along the oft-cited innovation hype cycle, in which we tend to overestimate the short-term impact of an innovation, while underestimating the long-term. Our own primary research corroborated this sentiment: AI was the healthcare innovation vector most often picked as likely to make a meaningful impact in the next five years but was also most frequently cited as overhyped.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.